OTCMKTS:ENZC Enzolytics (ENZC) Stock Price, News & Analysis $0.0005 0.00 (0.00%) As of 02:09 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChart About Enzolytics Stock (OTCMKTS:ENZC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Enzolytics alerts:Sign Up Key Stats Today's Range$0.0004▼$0.000550-Day Range N/A52-Week Range$0.0002▼$0.0013Volume2.42 million shsAverage Volume7.82 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Enzolytics, Inc. is a biotechnology company focused on developing therapeutic products for infectious diseases. The company’s research centers on monoclonal antibodies and immune-based treatments designed to target viruses and other disease-causing agents. Enzolytics has highlighted ITV-1, an investigational HIV treatment, as well as antibody-based programs directed at HIV, SARS-CoV-2 and other viral diseases. Its work includes the development and testing of humanized monoclonal antibodies intended for potential therapeutic applications. The company is based in the United States and has reported collaborations and international relationships related to the development of its infectious-disease programs. Product candidates remain subject to applicable scientific, clinical and regulatory requirements, and the company’s therapies are not necessarily approved for commercial use.AI Generated. May Contain Errors. Read More Receive ENZC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enzolytics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ENZC Stock News HeadlinesEnzolytics Inc.May 28, 2026 | marketwatch.comEnzolytics Stock Price HistoryMay 10, 2026 | investing.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 6 at 1:00 AM | Porter & Company (Ad)Enzolytics, Inc. (ENZC)April 19, 2024 | finance.yahoo.comEnzolytics, Inc.: Update on Formulation of New Business StrategyApril 12, 2024 | finanznachrichten.deEnzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on LongevityJanuary 16, 2024 | finance.yahoo.comEnzolytics Inc ENZCNovember 11, 2023 | morningstar.comM"Exploring Penny Stocks: Four Watchlist Options" FTRS, ELTP, ENZC, ZOMOctober 31, 2023 | benzinga.comSee More Headlines ENZC Stock Analysis - Frequently Asked Questions How have ENZC shares performed this year? Enzolytics' stock was trading at $0.0003 on January 1st, 2026. Since then, ENZC shares have increased by 66.7% and is now trading at $0.0005. How do I buy shares of Enzolytics? Shares of ENZC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Enzolytics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Enzolytics investors own include HUMBL (HMBL), Bionano Genomics (BNGO), Artificial Intelligence Technology Solutions (AITX), Meta Platforms (META), SNDL (SNDL), Tesla (TSLA). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorCommunication Services Industry Entertainment Sub-IndustryMovies & Entertainment Current SymbolOTCMKTS:ENZC CIKN/A Webenzolytics.com Phone(972) 292-9414FaxN/AEmployees1Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:ENZC) was last updated on 10/6/2026 by MarketBeat.com Staff. From Our PartnersNvidia’s record quarter could send this new type of AI soaringNvidia just posted 96.2 billion in revenue for a single quarter, more than Coca-Cola generates in an entire ye...Brownstone Research | SponsoredThey're not telling you how bad this could getValuations have reached levels seen only a handful of times in the past century, while debt concerns and tarif...Parkview Capital Group | SponsoredElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredThis smart glasses tech is bringing the screen to your eyesGlobal AI smart-glasses shipments surged 263% in the first half of 2026, and Citi projects the market could re...The Tomorrow Investor | SponsoredFeds Say Your Cash Isn’t Property—Can They Take It?The Department of Justice recently argued in court that cash may not qualify as legal property. That raises...Priority Gold | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzolytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzolytics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.